[OS1-12D-2] Phase 1 study of ibrutinib in Japanese patients with treatment-naive CLL/SLL
Abstract password authentication.
Password is written on a program and abstract book.
Oral Session
Fri. Oct 12, 2018 4:20 PM - 5:20 PM No.12 (Osaka International Convention Center, 10F 1006-7)
Chair: Naoki Mori (Tokyo Women's Medical University, Japan)
【E】
Abstract password authentication.
Password is written on a program and abstract book.